Literature DB >> 8280055

Tryptophan fluorescence study on the interaction of pulmonary surfactant protein A with phospholipid vesicles.

C Casals1, E Miguel, J Perez-Gil.   

Abstract

The fluorescence characteristics of surfactant protein A (SP-A) from porcine and human bronchoalveolar lavage were determined in the presence and absence of lipids. After excitation at either 275 or 295 nm, the fluorescence emission spectrum of both proteins was characterized by two maxima at about 326 and 337 nm, indicating heterogeneity in the emission of the two tryptophan residues of SP-A, and also revealing a partially buried character for these fluorophores. Interaction of both human and porcine SP-A with various phospholipid vesicles resulted in an increase in the fluorescence emission of tryptophan without any shift in the emission wavelength maxima. This change in intrinsic fluorescence was found to be more pronounced in the presence of dipalmitoyl phosphatidylcholine (DPPC) than with dipalmitoyl phosphatidylglycerol (DPPG), DPPC/DPPG (7:3, w/w) and 1-palmitoyl-sn-glycerol-3-phosphocholine (LPC). Intrinsic fluorescence of SP-A was almost completely unaffected in the presence of egg phosphatidylcholine (egg-PC). In addition, we demonstrated a shielding of the tryptophan fluorescence from quenching by acrylamide on interaction of porcine SP-A with DPPC, DPPG or LPC. This shielding was most pronounced in the presence of DPPC. In the case of human SP-A, shielding was only observed on interaction with DPPC. From the intrinsic fluorescence measurements as well as from the quenching experiments, we concluded that the interaction of some phospholipid vesicles with SP-A produces a conformational change on the protein molecule and that the interaction of SP-A with DPPC is stronger than with other phospholipids. This interaction appeared to be independent of Ca2+ ions. Physiological ionic strength was found to be required for the interaction of SP-A with negatively charged vesicles of either DPPG or DPPC/DPPG (7:3, w/w). Intrinsic fluorescence of SP-A was sensitive to the physical state of the DPPC vesicles. The increase in intrinsic fluorescence of SP-A in the presence of DPPC vesicles was much stronger when the vesicles were in the gel state than when they were in the liquid-crystalline state. The effect produced by SP-A on the lipid vesicles was also dependent on temperature. The aggregation of DPPC, DPPC/DPPG (7:3, w/w) or dimyristoyl phosphatidylglycerol (DMPG) was many times higher below the phase-transition temperature of the corresponding phospholipids. These results strongly indicate that the interaction of SP-A with phospholipid vesicles requires the lipids to be in the gel phase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280055      PMCID: PMC1137738          DOI: 10.1042/bj2960585

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Binding of calcium to SP-A, a surfactant-associated protein.

Authors:  H P Haagsman; T Sargeant; P V Hauschka; B J Benson; S Hawgood
Journal:  Biochemistry       Date:  1990-09-25       Impact factor: 3.162

2.  Fourier-transform infrared spectroscopy studies of lipid/protein interaction in pulmonary surfactant.

Authors:  K E Reilly; A J Mautone; R Mendelsohn
Journal:  Biochemistry       Date:  1989-09-05       Impact factor: 3.162

3.  Comparison between intra- and extracellular surfactant in respiratory distress induced by oleic acid.

Authors:  C Casals; L Herrera; E Miguel; P Garcia-Barreno; A M Municio
Journal:  Biochim Biophys Acta       Date:  1989-06-08

4.  Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis.

Authors:  A J Tenner; S L Robinson; J Borchelt; J R Wright
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

5.  A captive bubble method reproduces the in situ behavior of lung surfactant monolayers.

Authors:  S Schürch; H Bachofen; J Goerke; F Possmayer
Journal:  J Appl Physiol (1985)       Date:  1989-12

6.  Hydrolytic action of phospholipase A2 in monolayers in the phase transition region: direct observation of enzyme domain formation using fluorescence microscopy.

Authors:  D W Grainger; A Reichert; H Ringsdorf; C Salesse
Journal:  Biochim Biophys Acta       Date:  1990-04-30

7.  Molecular species of phosphatidylcholine and phosphatidylglycerol in rat lung surfactant and different pools of pneumocytes type II.

Authors:  M Schlame; C Casals; B Rüstow; H Rabe; D Kunze
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

8.  Effects of a surfactant-associated protein and calcium ions on the structure and surface activity of lung surfactant lipids.

Authors:  S Hawgood; B J Benson; R L Hamilton
Journal:  Biochemistry       Date:  1985-01-01       Impact factor: 3.162

9.  Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant.

Authors:  Y Suzuki; Y Fujita; K Kogishi
Journal:  Am Rev Respir Dis       Date:  1989-07

10.  Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages.

Authors:  F van Iwaarden; B Welmers; J Verhoef; H P Haagsman; L M van Golde
Journal:  Am J Respir Cell Mol Biol       Date:  1990-01       Impact factor: 6.914

View more
  20 in total

1.  Differential effects of surfactant protein A on regional organization of phospholipid monolayers containing surfactant protein B or C.

Authors:  S G Taneva; K M Keough
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

2.  A phosphorylation-regulated amphipathic helix controls the membrane translocation and function of the yeast phosphatidate phosphatase.

Authors:  Eleftherios Karanasios; Gil-Soo Han; Zhi Xu; George M Carman; Symeon Siniossoglou
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

3.  Effects of bilayer surface charge density on molecular adsorption and transport across liposome bilayers.

Authors:  Y Liu; E C Yan; K B Eisenthal
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

4.  Surfactant protein A (SP-A) binds to phosphatidylserine and competes with annexin V binding on late apoptotic cells.

Authors:  Anne Jäkel; Kenneth B M Reid; Howard Clark
Journal:  Protein Cell       Date:  2010-02-06       Impact factor: 14.870

5.  Fluorescence spectroscopy measures yeast PAH1-encoded phosphatidate phosphatase interaction with liposome membranes.

Authors:  Zhi Xu; Wen-Min Su; George M Carman
Journal:  J Lipid Res       Date:  2011-12-16       Impact factor: 5.922

6.  Effect of surfactant protein A on the physical properties and surface activity of KL4-surfactant.

Authors:  Alejandra Sáenz; Olga Cañadas; Luís A Bagatolli; Fernando Sánchez-Barbero; Mark E Johnson; Cristina Casals
Journal:  Biophys J       Date:  2006-10-20       Impact factor: 4.033

7.  Pulmonary surfactant protein A interacts with gel-like regions in monolayers of pulmonary surfactant lipid extract.

Authors:  L A Worthman; K Nag; N Rich; M L Ruano; C Casals; J Pérez-Gil; K M Keough
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

8.  Interaction of SP-A (surfactant protein A) with bacterial rough lipopolysaccharide (Re-LPS), and effects of SP-A on the binding of Re-LPS to CD14 and LPS-binding protein.

Authors:  Ignacio García-Verdugo; Fernando Sánchez-Barbero; Katrin Soldau; Peter S Tobias; Cristina Casals
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

9.  Differential partitioning of pulmonary surfactant protein SP-A into regions of monolayers of dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylcholine/dipalmitoylphosphatidylglycerol.

Authors:  M L Ruano; K Nag; L A Worthman; C Casals; J Pérez-Gil; K M Keough
Journal:  Biophys J       Date:  1998-03       Impact factor: 4.033

10.  Comparison of lipid aggregation and self-aggregation activities of pulmonary surfactant-associated protein A.

Authors:  M L Ruano; E Miguel; J Perez-Gil; C Casals
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.